Moderna shares are trading lower after the company reported Q3 financial results and issued FY23 and FY24 guidance.
Portfolio Pulse from Benzinga Newsdesk
Moderna's shares are trading lower following the release of its Q3 financial results and the issuance of FY23 and FY24 guidance.
November 02, 2023 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock is trading lower after the company reported its Q3 financial results and issued FY23 and FY24 guidance.
The drop in Moderna's stock price is directly linked to the company's Q3 financial results and the issuance of FY23 and FY24 guidance. Investors may have reacted negatively to the financial results or the future guidance, leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100